Literature DB >> 26792920

Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis.

Adriaan W Schneider1, Mark G Hazekamp1, Michel I M Versteegh1, Eline F Bruggemans1, Eduard R Holman2, Robert J M Klautz1, Jerry Braun3.   

Abstract

OBJECTIVES: Infective endocarditis of the aortic valve with local aortic root destruction requires radical resection of infected tissues and subsequent reconstruction of periannular structures and the left ventricular outflow tract (LVOT). Homografts or stentless bioprostheses are recommended for use in this specific patient group. The Freestyle stentless bioprosthesis is a porcine aortic root prosthesis, which approaches the surgical versatility of the homograft, but has the advantage of ready availability and uniform quality. We assessed clinical and echocardiographic outcome following the use of this prosthesis in extensive aortic valve endocarditis.
METHODS: Between June 2000 and December 2014, 55 Freestyle prostheses were implanted for aortic valve endocarditis involving the root in 54 patients (74% male). The mean age at operation was 61 ± 13 years. The mean EuroSCORE II was 20.1 ± 13.5. Twenty-nine (54%) patients had prosthetic valve endocarditis. The median follow-up time after surgery was 3.5 years, ranging from 0 to 15 years.
RESULTS: Early and late mortality were 11% (6 patients) and 14% (7 patients), respectively. Estimated overall survival at 1 and 5 years was 83 and 70%, respectively. There was no survival difference between patients with native or prosthetic valve endocarditis. One patient underwent reoperation for recurrent endocarditis 2.3 years after the initial procedure. No other prosthesis failure occurred. At a median follow-up of 3.3 years, mean gradient over the prosthesis was 4.3 ± 2.3 mmHg. No patient had more than mild aortic regurgitation.
CONCLUSIONS: The Freestyle stentless bioprosthesis is a valuable option to reconstruct the LVOT after debridement in extensive aortic valve endocarditis. It is readily available with a versatility and clinical outcome comparable with that of homografts. Although early mortality remains considerable in this high-risk group of patients, late survival is good with low rates of recurrence of endocarditis, immediate local control and good haemodynamic performance on echocardiography.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic root abscess; Aortic root replacement; Infective endocarditis; Stentless bioprosthesis

Mesh:

Year:  2016        PMID: 26792920     DOI: 10.1093/ejcts/ezv463

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  A standardized approach to treat complex aortic valve endocarditis: a case series.

Authors:  Anna Gomes; Jayant S Jainandunsing; Sander van Assen; Peter Paul van Geel; Bhanu Sinha; Sandro Gelsomino; Daniel M Johnson; Ehsan Natour
Journal:  J Cardiothorac Surg       Date:  2018-04-19       Impact factor: 1.637

2.  Reinterventions after freestyle stentless aortic valve replacement: an assessment of procedural risks.

Authors:  Adriaan W Schneider; Mark G Hazekamp; Michel I M Versteegh; Arend de Weger; Eduard R Holman; Robert J M Klautz; Eline F Bruggemans; Jerry Braun
Journal:  Eur J Cardiothorac Surg       Date:  2019-12-01       Impact factor: 4.191

3.  Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes.

Authors:  Giuseppe Nasso; Giuseppe Santarpino; Marco Moscarelli; Ignazio Condello; Angelo Maria Dell'Aquila; Armin Darius Peivandi; Mario Gaudino; Flavio Fiore; Pasquale Mastroroberto; Nicola Di Bari; Giuseppe Speziale
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

4.  Impact of aortic root repair or replacement in severe destructive aortic valve endocarditis with paravalvular abscesses on long-term survival.

Authors:  Can Gollmann-Tepeköylü; Hannes Abfalterer; Leo Pölzl; Ludwig Müller; Michael Grimm; Johannes Holfeld; Nikolaos Bonaros; Katie Bates; Hanno Ulmer; Elfriede Ruttmann
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

5.  Systematic review and meta-analysis of surgical outcomes comparing mechanical valve replacement and bioprosthetic valve replacement in infective endocarditis.

Authors:  Campbell D Flynn; Neil P Curran; Stephanie Chan; Isabel Zegri-Reiriz; Manel Tauron; David H Tian; Gosta B Pettersson; Joseph S Coselli; Martin Misfeld; Manuel J Antunes; Carlos A Mestres; Eduard Quintana
Journal:  Ann Cardiothorac Surg       Date:  2019-11

6.  Treatment of aortic valve endocarditis with stented or stentless valve.

Authors:  Jeffrey Clemence; Juan Caceres; Tom Ren; Xiaoting Wu; Karen M Kim; Himanshu J Patel; G Michael Deeb; Bo Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2020-08-26       Impact factor: 6.439

7.  Root abscess in the setting of infectious endocarditis: Short- and long-term outcomes.

Authors:  Bo Yang; Juan Caceres; Linda Farhat; Tan Le; Bailey Brown; Emma St Pierre; Xiaoting Wu; Karen M Kim; Himanshu J Patel; G Michael Deeb
Journal:  J Thorac Cardiovasc Surg       Date:  2020-04-13       Impact factor: 6.439

8.  Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.

Authors:  Andreas Schaefer; Jannis Dickow; Gerhard Schoen; Sumi Westhofen; Lisa Kloss; Tarik Al-Saydali; Hermann Reichenspurner; Sebastian A Philipp; Christian Detter
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

9.  Surgical Options for Aortic Root Replacement in Destructive Endocarditis.

Authors:  Marcin Szczechowicz; Alexander Weymann; Sabreen Mkalaluh; Ahmed Mashhour; Konstantin Zhigalov; Jerry Easo
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01

10.  Stentless Root Replacement versus Tissue Valves in Infective Endocarditis - A Propensity-Score Matched Study.

Authors:  Jerry Easo; Marcin Szczechowicz; Philipp Hölzl; Adrian Meyer; Konstantin Zhigalov; Rizwan Malik; Rohit Philip Thomas; Alexander Weymann; Otto E Dapunt
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.